SCHEMBL28802433

SCHEMBL28802433

CNc1ccc(C)nc1OC(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GRM5 P41594 1/20 0.34
LPAR1 Q92633 7/20 0.34
CYP3A4 P08684 2/20 0.34
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LRRK2 Q5S007 1/20 0.32
CCR1 P32246 1/20 0.31
RAB9A P51151 1/20 0.31
CCR5 P51681 1/20 0.31
MAPK1 P28482 1/20 0.31
LMNA P02545 1/20 0.31
MAPK14 Q16539 1/20 0.30
BCL2 P10415 1/20 0.30
BCL2L1 Q07817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16693759 0.79 APOBEC3A (0.38) LPAR1SMN1; SMN2CCR1RAB9ACCR5
SCHEMBL21585395 0.76 KMT2A (0.41) MEN1KMT2AGRM5CYP1A2POLB
SCHEMBL27885274 0.76 TRPV1 (0.42) LRRK2
SCHEMBL23458439 0.73 CCNA2 (0.37) MEN1KMT2AGRM5POLBLRRK2
SCHEMBL1840667 0.73 MEN1 (0.36) MEN1KMT2AGRM5CYP1A2POLB
SCHEMBL29983687 0.73 CCNA2 (0.37) MEN1KMT2AGRM5POLBLRRK2
Acetonitrile SCHEMBL27976112 0.71 TRPV1 (0.39) MEN1KMT2ALRRK2
SCHEMBL4477938 0.70 MKNK2 (0.42) GRM5LRRK2
SCHEMBL1145111 0.69 LMNA (0.48) MEN1KMT2ACYP2D6LMNA
SCHEMBL2547927 0.69 MEN1 (0.40) MEN1KMT2AGRM5CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102858742-B Trpv1 vanilloid receptor antagonists with a bicyclic portion PHARMESTE SRL 2015-05-27 CN disclosed
CN-102858742-A Trpv1 vanilloid receptor antagonists with a bicyclic portion PHARMESTE SRL 2013-01-02 CN disclosed